Premalignant gastric conditions, such as: Atrophic gastritis, Intestinal metaplasia, Dysplasia
Conditions
Interventions
No new treatment or medical device is being investigated. The only ‘intervention’ in this study is the recording of procedure time during standard upper gastrointestinal endoscopy (UGE). Two time metr
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria:Age 18 years or olderUndergoing diagnostic or surveillance UGE for premalignant gastric conditionsAble and willing to provide written informed consent
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: History of esophagus, stomach, or duodenum surgeryKnown or suspected gastrointestinal neoplasia requiring therapeutic interventionUndergoing therapeutic endoscopic procedures (e.g., polypectomy, hemostasis) during the scheduled UGE
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate whether withdrawal time or total procedure time is the better metric for measuring inspection time in upper gastrointestinal endoscopy (UGE), in terms of maximizing the detection rate of premalignant and malignant lesions. | — |
Secondary
| Measure | Time frame |
|---|---|
| Procedure-related complications (e.g., sedation-related, cardiopulmonary events, bleeding, perforation)Patient tolerance (classified as well tolerated, poorly tolerated, or interrupted)Mucosal visibility score (GRACE scale)Differences in procedure time metrics (total procedure time vs. withdrawal time) | — |
Countries
Belgium, Brazil, Ireland, Italy, Netherlands, Portugal, Spain
Contacts
Public ContactJ Honing
Erasmus MC, Universitair Medisch Centrum Rotterdam
Outcome results
None listed